M. De Jong‐Bakker

Insulin resistance and breast‐cancer risk

Peter F. Bruning, Johannes M.G. Bonfrèr, P.A.H. van Noord et al. · International Journal of Cancer · 1992 · 360 citations

Insulin Resistance, Metabolic Syndrome, Breast Oncology +13

Bone mineral density after adjuvant chemotherapy for premenopausal breast cancer

PF Bruning, M.J Pit, M. De Jong‐Bakker et al. · British Journal of Cancer · 1990 · 182 citations · Full text

Bone Disease, Breast Oncology, Bone Health +9

Tamoxifen, serum lipoproteins and cardiovascular risk

PF Bruning, JMG Bonfrer, A.A.M. Hart et al. · British Journal of Cancer · 1988 · 147 citations · Full text

Metabolic Syndrome, Hypertension, Cardiovascular Epidemiology +10

MAM-6 antigen, a new serum marker for breast cancer monitoring.

John Hilkens, V. Kroezen, J. M. G. Bonfrer et al. · PubMed · 1986 · 132 citations

Biomarker (Medicine), Iv Breast Cancer, Breast Oncology +15

Body measurements, estrogen availability and the risk of human breast cancer: A case‐control study

P.F. Bruning, Johannes M.G. Bonfrèr, A.A.M. Hart et al. · International Journal of Cancer · 1992 · 116 citations

Nutrition, Breast Oncology, Nutritional Epidemiology +23